After a rough year in the trenches, Alnylam CEO John Maraganore and his team take a big cut in compensation
Alnylam CEO John Maraganore had a tough year in 2016. In early October the biotech’s stock plunged in the wake of his decision to scrap a late-stage program. But since then the company $ALNY has clawed back much of its lost market cap.
Now, to top it off, his compensation has dropped precipitously as the company looks to spread the wealth in new ways.
According to Alnylam’s proxy statement, Maraganore’s total compensation for 2016 was $1,744,842 — far below the glory days of 2015, when he scored total compensation of $8,261,158. Maraganore’s base pay edged up slightly to $731,600.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.